Melissa Leung Australian and New Zealand Obesity Society Annual Scientific Conference 2024

Abstracts this author is presenting:

• Efficacy of tirzepatide in achieving the composite endpoints of glycemic, blood pressure and lipid goals in SURMOUNT-2 — Poster Session Day 2
• Semaglutide improves cardiovascular outcomes in patients with high risk for metabolic dysfunction-associated steatohepatitis – a subgroup analysis from the SELECT trial — Concurrent 6 - Clinical Science Oral Abstracts: Obesity and weight management- preconception to early childhood
• Semaglutide and cardiovascular outcomes in patients with overweight or obesity who do not have diabetes — Poster Session Day 2